ClinicalTrials.gg
RecruitingNCT07458568Updated Nov 13, 2026

ViBandz Feasibility Study

An observational study in Pediatrics, Neurologic Dysfunction and Vibration Therapy, sponsored by Children's Mercy Hospital Kansas City. Recruiting at 1 site in United States. Open to participants aged 6 Months to 17 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Children's Mercy Hospital Kansas City · Observational

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.
Updated Nov 13, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
6 Months to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 185 studies in Neurologic Manifestations with a site in United States — 24 open to participants now, 38 under way, 6 of them phase 3. Neurologic Manifestations · United States.

Planned enrollment
41st of 47
30 · median 100
Started
2026
with 8 others
Observational
47 of 185
6 open now
Primary completion
2027-03
later than 12 of 37 live
Registered
181st of 185
by date

Among the 185 studies in Neurologic Manifestations with a site in United States, this one is the 41st largest by planned enrollment of the 47 observational ones that give a count, is one of 9 that started in 2026, is one of 47 observational ones, reaches primary completion later than 12 of the 37 other live ones, and was the 181st registered.

Neurologic Manifestations

427 studies on the registry are indexed under Neurologic Manifestations; 80 are open to participants now.

Browse Neurologic Manifestations studies →

Open to participants now

24 of the 185 studies in Neurologic Manifestations with a site in United States are open now. Recruiting first, the newest first:

18 more — sign in →

All 24 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 59 Neurologic Manifestations studies recruiting now, 31 (53%) set no upper age limit and 15 (25%) stop at 75 or younger; 15 take children under 18; 12 take healthy volunteers.

This study: 6 Months to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 185 studies in Neurologic Manifestations with a site in United States, or all of them as a file.
02

Study summary

This is a single site, mixed methods, feasibility study of the ViBandz device at a Midwest pediatric tertiary care hospital in a physical and occupational therapy clinic.

Read the detailed description

This proposal is for a single-site, feasibility study of the use of ViBandz in a treatment population. The analysis is a mixed methods approach with quantitative feedback on surveys and a secondary qualitative review of audio/+/- video that was obtained during the device use. The survey will be done immediately after the study on a device in clinic by the parents. If parents do not have time to finish it then, an email will be sent. Video and audio during the visit will provide additional rich data to understand the device beyond what a standard quantitative survey could provide. Subjects will have their standard clinical care- targeted vibration and then after their visit is completed, they will complete the use of the ViBandz This order will occur with all participants.

03

Conditions studied

  • Pediatrics
  • Neurologic Dysfunction
  • Vibration Therapy

Keywords

  • pediatrics
  • vibration therapy
04

Who can participate

Ages eligible
6 Months to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Minimum of 15 children and their parent/LAR (dyad) who have a neurologic condition resulting in abnormal movement of at least one extremity to be enrolled at Children's Mercy Hospital.

Eligibility criteria

Inclusion Criteria (Children):

  • Children of ages 6 months to 17 years old
  • Neurologic conditions resulting in abnormal movement of at least one extremity
  • Appointment scheduled in CM PT/OT clinic that would include targeted focal vibration as a standard of care

Exclusion Criteria (Children):

  • Wards of the state

Inclusion Criteria (Parent/LAR):

  • Parent or Legally Authorized Representative of a child with inclusion criteria above
  • English-speaking

Exclusion Criteria (Parent/LAR):

  • Non-English speaking
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Interventions

  • DeviceViBandz

    ViBandz is a device with straps and small vibrating motors that can be worn over muscles for stimulation and targeted vibration therapy. It was created to address the need for a hands-free vibrating device. There are different motor sizes and strap sizes for best fit with the patient. ViBandz also features a base station for powering the device and a key fob used to control the vibration therapy. Once all appropriate signatures have been obtained and all family/subject questions have been addressed, the subject will undergo their scheduled standard clinical Care (SOC) visit. The time with the ViBandz (10-15 minutes) will be less than full traditional targeted therapy (45 minutes) will help to control for subject fatigue as the vibration feeling stimulates muscles.: Video recordings via an iPad or similar device may be obtained during the subject's visit. These videos will allow for a closer inspection of subject interaction with the ViBandz.

06

What researchers measure

Primary outcomes

  1. End User System Usability Feedback on ViBandz

    Overall themes to be investigated will include ease of use, perceived comfort in using the ViBandz in the home setting, suggestions for changes/improvements to the ViBandz, and any additional comments. This will be gathered through the use of the System Usability Survey that will be administered via REDCap to parents following use of the ViBandz device for targeted vibration therapy.

    Time frame: 3-6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Mar 2027, 11 months after the start.

Of 52 non-industry observational studies under Neurologic Manifestations, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 339. This study's planned 11 months is below that.

Counting every sponsor, half of 59 studies reached it within 39 months; a quarter within 22 and three quarters within 339.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Oct 2026 → Mar 2027 and completion Dec 2026 → Mar 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2026
First posted
Mar 9, 2026
StartActual
Apr 7, 2026
Primary completionEst.
Mar 31, 2027was Oct 2026
CompletionEst.
Mar 31, 2027was Dec 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 31, 2026→Mar 31, 2027
Nov 13, 2026
Study completion
Dec 31, 2026→Mar 31, 2027
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Primary completion Oct 31, 2026→Mar 31, 2027
    Study completion Dec 31, 2026→Mar 31, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07458568
Responsible party
Megan Blaufuss (Education Coordinator - PTOT, Children's Mercy Hospital Kansas City) — Principal investigator
First posted
Mar 9, 2026
Start date
Apr 7, 2026
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Megan Blaufuss, OTR/L, MS, CPAM
Contact
mmblaufuss@cmh.edu
913-696-5028 ext. 85028
Ryan Thompson, MS
Contact
rmthompson@cmh.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion